Back to search
FDAFDA · Food and drugs·Recall number D-379-2014

FOLIC ACID INJECTION, USP; 5 mg/mL ; For IM, IV or SC Use; 10 mL; Multiple Dose Vial; Rx only; APP Pharmaceuticals, LLC; Schaumburg, IL 60173 NDC 63323-184-11

Published December 25, 2013 · Recall initiated: December 6, 2013

Summary

FDA records drug Class III recall D-379-2014, published December 25, 2013 and initiated December 6, 2013. Recalling firm: Fresenius Kabi USA, LLC; Status: Terminated; Reported quantity: 215,340 vials; Lot: Lot 6104649, Exp. 02/14; 6104789, Exp. 03/14; 6105069, Exp. 04/14. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation specifications: out-of-specification results 14 & 15 month time point

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Fresenius Kabi USA, LLC
Distributor
Nationwide, Puerto Rico, Canada, New Zealand
Lot
Lot 6104649, Exp. 02/14; 6104789, Exp. 03/14; 6105069, Exp. 04/14
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was FOLIC ACID INJECTION, USP; 5 mg/mL ; For IM, IV or SC Use; 10 mL; Multiple Dose Vial; Rx only; APP Pharmaceuticals, LLC; Schaumburg, IL 60173 NDC 63323-184-11 recalled?

Yes. FDA published recall D-379-2014 on December 25, 2013. Reported hazard: Failed Impurities/Degradation specifications: out-of-specification results 14 & 15 month time point

What should I do if I have this product?

Voluntary: Firm initiated · Letter